The benefits of HIPEC include improved local control of cancer, reduced recurrence rates, and enhanced survival outcomes for ...

Peritoneal Cancer Market Outlook 2025-2035: The 7 major Peritoneal Cancer Market are expected to exhibit a CAGR of 18.7% during 2025-2035. The peritoneal cancer market is growing, as people become ...

USA Cancer originating from organs in the peritoneal cavity (e.g., ovarian, pancreatic, colorectal, gastric, liver and peritoneal mesothelioma) account for approximately 250,000 new cases of ...

Alphamab Oncology has dosed the first subject in the randomised Phase III JSKN003-306 trial of its anti-human epidermal ...

Alphamab Oncology (stock code: 9966.HK) announced that the first patient has been successfully dosed in the Phase III clinical study (Study ID: JSKN003-306) of anti-HER2 biparatopic antibody-drug ...

The guideline authors used data from 61 studies to provide recommendations on the use of neoadjuvant chemotherapy in patients with newly diagnosed, stage III-IV epithelial ovarian, fallopian tube, or ...

To date, surgery is the only potentially curative treatment for gastric cancer; however, more than two-thirds of patients have unresectable disease upon diagnosis (4). Peritoneal carcinomatosis, ...

Nesuparib is under clinical development by Onconic Therapeutics and currently in Phase II for Peritoneal Cancer. According to GlobalData, Phase II drugs for Peritoneal Cancer have a 37% phase ...

The Philippine Health Insurance Corporation (PhilHealth) has announced an enhancement to its Z Benefit Package for Peritoneal ...

Use precise geolocation data and actively scan device characteristics for identification. This is done to store and access ...